The Working Party endorsed this document at its 10th Meeting in June 2012.
It is intended to provide information on the outcomes and developments of the
WPMN related to the safety of manufactured nanomaterials.
The purpose of the agenda item 4 (the Tour de Table) is to give each
delegation the opportunity to describe recent or planned national initiatives
and/or events related to the safety of manufactured nanomaterials. This will
facilitate the implementation of the projects of the WPMN by allowing
delegations to share their experiences and preoccupations with respect to
safety, and will identify opportunities for future co-operation and
co-ordination.
In considering the Tour de Table, each delegation was invited to prepare a
short written paper. It was recommended that the information in these papers be
organised, where possible, under the headings identified below, while
recognising that not all delegations would be able to supply information under
each heading.
1) Highlight of developments since the 9t meeting of the WPMN
2) Work completed, underway or planned
1. Any national regulatory developments on human health and environmental
safety including recommendations or discussions related to adapting existing
regulatory systems or the drafting of laws/ regulations/ guidance materials;
2. Developments related to voluntary or stewardship schemes;
3. Information on any risk assessment decisions;
4. Information on any developments related to good practice documents;
5. Information on any developments related to Integrated Testing Strategies
and/or Alternative test methods
6. Research programmes or strategies designed to address human health and/
or environmental safety aspects of nanomaterials;
7. Information on any public/ stakeholder consultation;
8. Information on research programmes or strategies which focus on life
cycle aspects of nanomaterials, as well as positive and negative impacts on
environment and health of certain nano-enabled applications. (You may wish to
contact your colleagues participating in SG9.);
9. Information on any development related to exposure measurement and
exposure mitigation
10. Additional Information
- Any consideration on the benefits of nanotechnologies;
- Consideration of ethical implications; and
- Information on past, current or future activities on nanotechnologies
that are being done in your respective countries in co-operation on a bilateral
basis with non-OECD countries